Abstract
Encompassed by the term chronic lung disease (CLD) of prematurity is a sequence of pathophysiological processes ranging from acute inflammation and its resolution to remodelling and growth. There is good evidence for clinical and biological effects of parenteral corticosteroid therapy at each stage in the disease process. A number of questions remain to be resolved: can risk prediction be refined to permit trials of prevention; what is the minimum effective dosage regime; are topical corticosteroids effective; what are the long-term effects on lung growth and development and indeed, is the long-term prognosis of CLD affected by corticosteroid therapy? It is prudent to be cautious with steroids until these questions are answered.
Article PDF
Similar content being viewed by others
Abbreviations
- BAL :
-
bronchoalveolar lavage
- BPD :
-
bronchopulmonary dysplasia
- CLD :
-
chronic lung disease
- IL-6:
-
interleukin-6
- MDI :
-
metered dose inhaler
- RDS :
-
respiratory distress syndrome
References
Adamson IYR, King GM (1988) Postnatal development of rat lung following retarded fetal lung growth. Pediatr Pulmonol 4: 230–236
Arnold JG Leslie GI, Williams G, Rack P, Silink M (1987) Adrenocortical responsiveness in neonates weaned from the ventilator with dexamethasone. Austr Paediatr J 23: 227–229
Arnon S, Grigg J, Nikander K, Silverman M (1992) Delivery of micronised budesonide suspension by metered dose inhaler and jet nebulizer into a neonatal ventilator circuit Pediatr Pulmonol 13: 172–175
Arnon S, Grigg J, Silverman M (1993) Pulmonary inflammatory cells in ventilated preterm infants: effect of surfactant treatment. Arch Dis Child 69: 44–48
Asayama K, Hayashibe H, Dobashi K Uchida N, Kato K (1993) Effect of dexamethasone on antioxidant enzymes in fetal rat lungs and kidneys. Biol Neonate 62: 136–144
Avery GB, Fletcher AB, Kaplan M, Brudno DS (1985) Controlled trial of dexamethasone in respirator-dependent infants with bronchopulmonary dysplasia. Pediatrics 75: 106–111
Barker DJP (1992) Fetal and infant origins of adult disease. BMJ, London
Barnes PJ (1993) Nitric oxide and airways. Eur Resp J 6: 163–165
Basan MJ, Jones JJ, Brozanski BS, Fireman P, Guthrie RD (1993) Effects of pulse dexamethasone therapy on histamine levels in tracheobronchial lavage samples (TBLS) from premature infants with evolving bronchopulmonary dysplasia. Am Rev Respir Dis 147: A422
Beck JC, Mitzner W, Johnson JW, Hutchins GM, Foidart JM, London WT, Palmer AE, Scott R (1981) Betamethasone and the rhesus fetus: effect on lung morphometry and connective tissue. Pediatr Res 15: 235–240
Braude WC, Rebuck AS (1983) Prednisolone and methyl prednisolone disposition in the lung. Lancet II: 985–997
Brundage KL, Mohsini KG, Froese AB, Walker CR, Fisher JT (1992) Dexamethasone therapy for bronchopulmonary dysplasia improved respiratory mechanics without adrenal suppression. Pediatr Pulmonol 12: 162–169
Cambrey AD, Harrison NK, Grigg JM, McAnulty RJ, Silverman M (1992) Correlation of lavage protein concentration and mitogenic activity for fibroblasts in respiratory distress syndrome. Eur Respir Rev 2(9): 227
Chan KN, Silverman M (1993) Increased airway responsiveness in children of low birthweight at school age: effect of topical corticosteroids. Arch Dis Child 69: 120–124
Collaborative Dexamethasone Trial Group (1991) Dexamethasone therapy in neonatal chronic lung disease: an international placebo-controlled trial. Pediatrics 88: 421–427
Couser RJ, Ferrara B, Falde B, Johnson K, Schilling CG, Hoekstra RE (1992) Effectiveness of dexamethasone in preventing extubation failure in preterm infants at increased risk for airway edema. J Pediatr 121: 591–596
Crowley P (1991) Promoting pulmonary maturity. In: Chalmers (ed) Effective care in pregnancy and childbirth. Oxford University Press, Oxford, pp 746–764
Cummings JJ, D'Eugenio DB, Gross SJ (1989) Controlled trial of dexamethasone in preterm infants at high risk for bronchopulmonary dysplasia. N Engl J Med 320: 1505–1510
De Lemos RA, Coalson JJ (1992) The contribution of experimental models to our understanding of the pathogenesis and treatment of bronchopulmonary dysplasia. Clin Perinatol 19: 521–539
De Souza SW, Adlard BPF (1973) Growth of suckling rats after treatment with dexamethasone or cortisol. Arch Dis Child 48: 519–522
Dunn MS, Magnani L, Belaiche M (1989) Inhaled corticosteroids in severe bronchopulmonary dysplasia. Pediatr Res 25: 213A
Ehrenkranz RA, Mercurio MR (1992) Bronchopulmonary dysplasia. In: Sinclair JC, Bracken MB (eds) Effective care of the newborn infant. Oxford University Press, Oxford, pp 399–424
Ferrara TB, Georgieff MK, Ebert J, Fisher JB (1989) Routine use of dexamethasone for prevention of postextubation respiratory distress. J Perinatol 9: 287–290
Gau GS, Ryder TA, Mobberley MA (1987) Iatrogenic epithelial change caused by endotracheal intubation of neonates. Early Hum Dev 15: 221–229
Gerdes JS, Harris MC, Polin RA (1988) Effects of dexamethasone and indomethacin on elastase, a1-protease inhibitor and fibronectin in bronchoalveolar lavage fluid from neonates. J Pediatr 113: 727–731
Gladstone IM, Ehrenkrantz RA, Jacobs HC (1989) Pulmonary function tests and fluid balance in neonates with chronic lung disease during dexamethasone treatment. Pediatrics 84: 1072–1076
Grigg J, Arnon S, Jones T, Clark A, Silverman M (1992) Delivery of therapeutic aerosols to intubated babies. Arch Dis Child 67: 25–30
Grigg J, Barber A, Silverman M (1992) Increased levels of bronchoalveolar lavage fluid interleukin-6 in preterm ventilated infants after prolonged rupture of membranes. Am Rev Respin Dis 145: 782–786
Grigg JM, Savill JS, Sarraf C, Haslett C, Silverman M (1991) Neutrophil apoptosis and clearance from neonatal lungs. Lancet 338: 720–722
Harkavy KL, Scanlon IW, Chowdhry PR, Grylack LJ (1989) Dexamethasone for chronic lung disease in ventilator and oxygen dependent infants: a controlled trial. J Pediatr 115: 979–983
Hislop AA, Haworth SG (1989) Airway size and structure in the normal fetal and infant lung and the effect of premature delivery and artificial ventilation. Am Rev Respir Dis 140: 1717–1726
Hislop AA, Wigglesworth JS, Desai R, Aber V (1987) The effects of preterm delivery and mechanical ventilation on human lung growth. Early Hum Dev 15: 147–164
Jefferies AL, Coates C, O'Brodovich H (1984) Pulmonary epithelial permeability in hyaline membrane disease. N Engl J Med 311: 1075–1080
Kari MA, Heinonen K, Ikonen RS, Koivisto M, Raivio KO (1993) Dexamethasone treatment in preterm infants at risk for bronchopulmonary dysplasia. Arch Dis Child 68: 566–569
Kazzi NJ, Brans YW, Poland RL (1990) Dexamethasone effects on the hospital course of infants with bronchopulmonary dysplasia who are dependent on artificial ventilation. Pediatrics 86: 722–727
Kelly EJ, Chatfield SL, Brownlee KG, Ng PC, Newell SJ, Dear PRF, Primrose JN (1993) The effect of intravenous ranitidine on the intragastric pH of preterm infants receiving dexamethasone. Arch Dis Child 69: 37–39
La Force WR, Brudno DS (1993) Controlled trial of beclomethasone dipropionate by nebulisation in oxygen-dependent and ventilator-dependent infants. J Pediatr 122: 285–288
Mammel MC, Green TP, Johnson DE, Thompson TR (1983) Controlled trial of dexamethasone therapy in infants with bronchopulmonary dysplasia. Lancet 1: 1356–1358
Manescalco WM, Shapiro (1983) Effects of dexamethasone on beta-adrenergic receptors in fetal lung explants. Pediatr Res 17: 274–277
Massaro D, Teich N, Maxwell S, Massaro GD, Whitney P (1985) Postnatal development of alveoli. Regulation and evidence for a critical period in rats. J Clin Invest 76: 1297–1305
Mirro R, Armstead W, Leffler C (1990) Increased airway leukotriene levels in infants with severe bronchopulmonary dysplasia. Am J Dis Child 144: 160–161
Mitzner W, Johnson JW, Beck J, London W, Sly D (1982) Influence of betamethasone on the development of mechanical properties in the fetal rhesus monkey lung. Am Rev Respir Dis 125: 233–238
Murch SH, MacDonald TT, Wood CBS, Costeloe KL (1992) Tumour necrosis factor in bronchoalveolar secretions of infants with the respiratory distress syndrome and the effect of dexamethasone treatment. Thorax 47: 44–47
Ng PC (1993) The effectiveness and side-effects of dexamethasone in preterm infants with bronchopulmonary dysplasia. Arch Dis Child 68: 330–336
Noble-Jamieson CM, Regev R, Silverman M (1989) Dexamethasone in neonatal chronic lung disease: pulmonary effect and intracranial complications. Eur J Pediatr 148: 365–367
Northway WH (1990) Bronchopulmonary dysplasia: then and now. Arch Dis Child 65: 1076–1081
Ogden BE, Murphy SA, Saunders GC, Pathak D, Johnson JD (1984) Neonatal lung neutrophils and elastase/proteinase inhibitor imbalance. Am Rev Respir Dis 130: 817–821
Ohlsson A, Calvert SA, Hosking M, Shennan AT (1992) Randomised controlled trial of dexamethasone treatment in very-low-birthweight infants with ventilator dependent chronic lung disease. Acta Paediatr 81: 751–756
O'Neill EA, Chwals WJ, O'Shea MD, Turner CS (1992) Dexamethasone treatment during ventilator dependency: possible life-threatening gastrointestinal complications. Arch Dis Child 67: 10–11
Pappagallo M Blondheim D, Bhutani V, Abbasi S (1990) Effect of inhaled dexamethasone in ventilator dependent preterm infants. Pediatr Res 27: 219A
Richards IM, Shields SK, Griffin RL, Fidler SF, Dunn CJ (1992) Novel steroid-based inhibitors of lung inflammation. Clin Exp Allergy 22: 432–439
Rozycki HJ, Byron PR, Dailey K, Gutcher GR (1991) Evaluation of a system for the delivery of inhaled beclomethasone dipropionate to intubated neonates. Dev Pharmacol Ther 16: 65–70
Shennan HT, Dunn M, Ohlsson A, Lennox K, Hoskins EM (1988) Abnormal pulmonary outcomes in premature infants: prediction from oxygen requirement in neonatal period. Pediatrics 82: 527–532
Silverman M (1992) Chronic lung disease of prematurity. Monitor Respir Med 3: 103–106
Sinkin RA, Cox C, Phelps DC (1990) Predicting risk for bronchopulmonary dysplasia: selection criteria for clinical trials. Pediatrics 86: 728–736
Taylor IK, Shaw RJ (1993) The mechanism of action of corticosteroids in asthma. Respir Med 87: 261–277
The International Neonatal Network (1993) The CRIB (clinical risk index for babies) score: a tool for assessing initial neonatal risk and comparing performance of neonatal intensive care units. Lancet 342: 193–198
Walti H, Tordet C, Gerbaut L, Saugier P, Moriette G, Relier JP (1989) Persistent elastase/proteinase inhibitor imbalance during prolonged ventilation of infants with bronchopulmonary dysplasia: evidence for the role of nosocomial infections. Pediatr Res 26: 351–355
Watterberg KL, Demers LM, Murphy S (1993) Tracheal interleukin-1 in neonates who develop bronchopulmonary dysplasia. Pediatr Res 33: 349A
Watts CL, Bruce MC (1992) Effect of dexamethasone therapy on fibronectin and albumin levels in lung secretions of infants with bronchopulmonary dysplasia. J Pediatr 121: 597–607
Watts CL, Fanaroff AA (1993) In infants with bronchopulmonary dysplasia (BPD), interleukin-6 (IL-6) levels increase during treatment with dexamethasone. Am Rev Respir Dis 147: A422
Watts CL, Fanaroff AA (1993) Platelet-derived growth factor (PDGF) is increased in lung secretions during the first week of life in infants who develop bronchopulmonary dysplasia (BPD). Pediatr Res 33: 349A
Watts CL, Fanaroff AA (1993) Platelet-derived growth factor (PDGF) response to dexamethasone in infants with bronchopulmonary dysplasia (BPD). Pediatr Res 33: 349A
Whitsett JA (1991) Molecular aspects of the pulmonary surfactant system in the newborn. In: Chernick V, Mellins RB (eds) Basic mechanisms of paediatric respiratory disease. BC Decker Inc, Philadelphia, pp 303–314
Wiebicke W, Poynter A, Chernick V (1988) Normal lung growth following antenatal dexamethasone treatment for respiratory distress syndrome. Pediatr Pulmonol 5: 27–30
Wong YC, Beardsmore CS, Silverman M (1982) Antenatal dexamethasone and subsequent lung growth. Arch Dis Child 57: 536–538
Yeh TF, Torre JA, Rastogi A, Anyebuno MA, Pildes RS (1990) Early postnatal dexamethasone therapy in premature infants with severe respiratory distress syndrome: a double blind, controlled study. J Pediatr 117: 273–282
Yoder MC, Chua R, Tepper R (1991) Effect of dexamethasone on pulmonary inflammation and pulmonary function of ventilator-dependent infants with bronchopulmonary dysplasia. Am Rev Respir Dis 143: 1044–1048
Yuksel B, Greenough A (1992) Randomised trial of inhaled steroids in preterm infants with respiratory symptoms at follow up. Thorax 47: 910–913
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Silverman, M. Chronic lung disease of prematurity: are we too cautious with steroids?. Eur J Pediatr 153 (Suppl 2), S30–S35 (1994). https://doi.org/10.1007/BF02179671
Issue Date:
DOI: https://doi.org/10.1007/BF02179671